---
keywords:
  - Multimodal Learning
  - Prostate Cancer Prediction
  - Cox Regression
category: cs.CV
publish_date: 2025-09-23
arxiv_id: 2509.14051
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T05:32:27.399895",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Multimodal Learning",
    "Prostate Cancer Prediction",
    "Cox Regression"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Multimodal Learning": 0.85,
    "Prostate Cancer Prediction": 0.78,
    "Cox Regression": 0.68
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "fused multi-modal embeddings",
        "canonical": "Multimodal Learning",
        "aliases": [
          "multi-modal embeddings",
          "fused embeddings"
        ],
        "category": "specific_connectable",
        "rationale": "Multimodal Learning is a trending area that connects various data types, enhancing the prediction capabilities in medical applications.",
        "novelty_score": 0.55,
        "connectivity_score": 0.88,
        "specificity_score": 0.79,
        "link_intent_score": 0.85
      },
      {
        "surface": "prostate cancer biochemical recurrence prediction",
        "canonical": "Prostate Cancer Prediction",
        "aliases": [
          "PCa BCR prediction",
          "biochemical recurrence prediction"
        ],
        "category": "unique_technical",
        "rationale": "This is a specific application of predictive modeling in healthcare, focusing on a critical aspect of prostate cancer management.",
        "novelty_score": 0.72,
        "connectivity_score": 0.65,
        "specificity_score": 0.88,
        "link_intent_score": 0.78
      },
      {
        "surface": "Cox Proportional Hazard regressors",
        "canonical": "Cox Regression",
        "aliases": [
          "Cox model",
          "Proportional Hazard model"
        ],
        "category": "broad_technical",
        "rationale": "Cox Regression is a fundamental statistical technique for survival analysis, relevant across various research domains.",
        "novelty_score": 0.45,
        "connectivity_score": 0.82,
        "specificity_score": 0.7,
        "link_intent_score": 0.68
      }
    ],
    "ban_list_suggestions": [
      "radical prostatectomy",
      "prostate specific antigen"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "fused multi-modal embeddings",
      "resolved_canonical": "Multimodal Learning",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.88,
        "specificity": 0.79,
        "link_intent": 0.85
      }
    },
    {
      "candidate_surface": "prostate cancer biochemical recurrence prediction",
      "resolved_canonical": "Prostate Cancer Prediction",
      "decision": "linked",
      "scores": {
        "novelty": 0.72,
        "connectivity": 0.65,
        "specificity": 0.88,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Cox Proportional Hazard regressors",
      "resolved_canonical": "Cox Regression",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.82,
        "specificity": 0.7,
        "link_intent": 0.68
      }
    }
  ]
}
-->

# PROFUSEme: PROstate Cancer Biochemical Recurrence Prediction via FUSEd Multi-modal Embeddings

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250923|20250923]] [[categories/cs.CV|cs.CV]]
**PDF**: [Download](https://arxiv.org/pdf/2509.14051.pdf)
**Category**: cs.CV
**Published**: 2025-09-23
**ArXiv ID**: [2509.14051](https://arxiv.org/abs/2509.14051)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/ME-Mamba_ Multi-Expert Mamba with Efficient Knowledge Capture and Fusion for Multimodal Survival Analysis_20250923|ME-Mamba: Multi-Expert Mamba with Efficient Knowledge Capture and Fusion for Multimodal Survival Analysis]] (82.1% similar)
- [[2025-09-22/NeuroRAD-FM_ A Foundation Model for Neuro-Oncology with Distributionally Robust Training_20250922|NeuroRAD-FM: A Foundation Model for Neuro-Oncology with Distributionally Robust Training]] (81.6% similar)
- [[2025-09-23/Block-Fused Attention-Driven Adaptively-Pooled ResNet Model for Improved Cervical Cancer Classification_20250923|Block-Fused Attention-Driven Adaptively-Pooled ResNet Model for Improved Cervical Cancer Classification]] (81.5% similar)
- [[2025-09-19/Ensemble of Pathology Foundation Models for MIDOG 2025 Track 2_ Atypical Mitosis Classification_20250919|Ensemble of Pathology Foundation Models for MIDOG 2025 Track 2: Atypical Mitosis Classification]] (81.4% similar)
- [[2025-09-23/Unified Multimodal Coherent Field_ Synchronous Semantic-Spatial-Vision Fusion for Brain Tumor Segmentation_20250923|Unified Multimodal Coherent Field: Synchronous Semantic-Spatial-Vision Fusion for Brain Tumor Segmentation]] (81.3% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Cox Regression|Cox Regression]]
**ğŸ”— Specific Connectable**: [[keywords/Multimodal Learning|Multimodal Learning]]
**âš¡ Unique Technical**: [[keywords/Prostate Cancer Prediction|Prostate Cancer Prediction]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.14051v2 Announce Type: replace 
Abstract: Almost 30% of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) experience biochemical recurrence (BCR), characterized by increased prostate specific antigen (PSA) and associated with increased mortality. Accurate early prediction of BCR, at the time of RP, would contribute to prompt adaptive clinical decision-making and improved patient outcomes. In this work, we propose prostate cancer BCR prediction via fused multi-modal embeddings (PROFUSEme), which learns cross-modal interactions of clinical, radiology, and pathology data, following an intermediate fusion configuration in combination with Cox Proportional Hazard regressors. Quantitative evaluation of our proposed approach reveals superior performance, when compared with late fusion configurations, yielding a mean C-index of 0.861 ($\sigma=0.112$) on the internal 5-fold nested cross-validation framework, and a C-index of 0.7107 on the hold out data of CHIMERA 2025 challenge validation leaderboard.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì „ë¦½ì„ ì•” í™˜ìì˜ ìƒí™”í•™ì  ì¬ë°œ(BCR)ì„ ì¡°ê¸°ì— ì˜ˆì¸¡í•˜ê¸° ìœ„í•œ ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤. ì—°êµ¬ì—ì„œëŠ” ì„ìƒ, ë°©ì‚¬ì„ , ë³‘ë¦¬ ë°ì´í„°ë¥¼ ìœµí•©í•˜ì—¬ ë‹¤ì¤‘ ëª¨ë‹¬ ì„ë² ë”©ì„ í•™ìŠµí•˜ëŠ” PROFUSEme ëª¨ë¸ì„ ê°œë°œí–ˆìŠµë‹ˆë‹¤. ì´ ëª¨ë¸ì€ Cox ë¹„ë¡€ ìœ„í—˜ íšŒê·€ë¥¼ ì‚¬ìš©í•˜ì—¬ ì¤‘ê°„ ìœµí•© êµ¬ì„±ì—ì„œ ë°ì´í„°ë¥¼ ë¶„ì„í•©ë‹ˆë‹¤. ì œì•ˆëœ ë°©ë²•ì€ ë‚´ë¶€ 5ê²¹ êµì°¨ ê²€ì¦ì—ì„œ í‰ê·  C-ì§€ìˆ˜ 0.861ì„ ê¸°ë¡í•˜ë©°, CHIMERA 2025 ì±Œë¦°ì§€ ê²€ì¦ ë°ì´í„°ì—ì„œëŠ” C-ì§€ìˆ˜ 0.7107ì„ ë³´ì—¬ ê¸°ì¡´ì˜ í›„ê¸° ìœµí•© êµ¬ì„±ë³´ë‹¤ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë‚˜íƒ€ëƒˆìŠµë‹ˆë‹¤. ì´ë¥¼ í†µí•´ ì¡°ê¸° ì˜ˆì¸¡ì´ ê°€ëŠ¥í•´ì ¸ ì„ìƒì  ì˜ì‚¬ê²°ì •ê³¼ í™˜ì ê²°ê³¼ ê°œì„ ì— ê¸°ì—¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ì „ë¦½ì„ ì•” í™˜ìì˜ ìƒí™”í•™ì  ì¬ë°œ(BCR)ì„ ì¡°ê¸°ì— ì˜ˆì¸¡í•˜ëŠ” ê²ƒì€ ì„ìƒì  ì˜ì‚¬ ê²°ì •ê³¼ í™˜ì ê²°ê³¼ ê°œì„ ì— ê¸°ì—¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.
- 2. ë³¸ ì—°êµ¬ì—ì„œëŠ” ì„ìƒ, ë°©ì‚¬ì„ , ë³‘ë¦¬ ë°ì´í„°ë¥¼ ìœµí•©í•˜ì—¬ BCRì„ ì˜ˆì¸¡í•˜ëŠ” ë‹¤ì¤‘ ëª¨ë‹¬ ì„ë² ë”© ê¸°ë²•(PROFUSEme)ì„ ì œì•ˆí•©ë‹ˆë‹¤.
- 3. ì œì•ˆëœ ë°©ë²•ì€ Cox ë¹„ë¡€ ìœ„í—˜ íšŒê·€ ëª¨ë¸ê³¼ ê²°í•©í•˜ì—¬ ì¤‘ê°„ ìœµí•© êµ¬ì„±ì„ ë”°ë¥´ë©°, í›„ê¸° ìœµí•© êµ¬ì„±ë³´ë‹¤ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì…ë‹ˆë‹¤.
- 4. ë‚´ë¶€ 5ê²¹ ì¤‘ì²© êµì°¨ ê²€ì¦ì—ì„œ í‰ê·  C-ì§€ìˆ˜ 0.861ì„ ê¸°ë¡í•˜ì˜€ìœ¼ë©°, CHIMERA 2025 ì±Œë¦°ì§€ ê²€ì¦ ë¦¬ë”ë³´ë“œì˜ í™€ë“œ ì•„ì›ƒ ë°ì´í„°ì—ì„œ C-ì§€ìˆ˜ 0.7107ì„ ê¸°ë¡í–ˆìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-24 05:32:27*